---
title: "Golden Throat Profit Falls Over 20% in 2025 but Dividend Maintained"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/280842508.md"
description: "Golden Throat Holdings Group Co Ltd (HK:6896) reported a 20.4% decline in revenue for 2025, totaling RMB943.3 million, with gross profit down 19.8% to RMB717.0 million. Earnings before interest, taxes, depreciation, and amortization fell 22.9% to RMB377.1 million, and profit attributable to shareholders decreased by 21.2% to RMB251.2 million. Despite these declines, the company will maintain a final dividend of HK$0.34 per share, pending shareholder approval. Analysts rate the stock as a Buy with a price target of HK$3.50."
datetime: "2026-03-27T17:51:38.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/280842508.md)
  - [en](https://longbridge.com/en/news/280842508.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/280842508.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/280842508.md) | [繁體中文](https://longbridge.com/zh-HK/news/280842508.md)


# Golden Throat Profit Falls Over 20% in 2025 but Dividend Maintained

### Claim 30% Off TipRanks Premium

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

Golden Throat Holdings Group Co Ltd ( (HK:6896) ) just unveiled an announcement.

Golden Throat Holdings reported a sharp deterioration in 2025 results, with revenue falling 20.4% year on year to RMB943.3 million and gross profit down 19.8% to RMB717.0 million. Earnings before interest, taxes, depreciation and amortisation dropped 22.9% to RMB377.1 million, while profit attributable to shareholders slid 21.2% to RMB251.2 million, translating into basic earnings per share of RMB33.98 cents versus RMB43.10 cents a year earlier.

Despite the downturn, the board is recommending a final dividend of HK$0.34 per share for 2025, subject to shareholder approval at the upcoming annual general meeting. The maintained payout underlines the company’s continued emphasis on shareholder returns, even as weaker sales and profitability may raise concerns about demand dynamics and cost pressures in its core healthcare consumer products business.

The most recent analyst rating on (HK:6896) stock is a Buy with a HK$3.50 price target. To see the full list of analyst forecasts on Golden Throat Holdings Group Co Ltd stock, see the HK:6896 Stock Forecast page.

**More about Golden Throat Holdings Group Co Ltd**

Golden Throat Holdings Group Company Limited, incorporated in the Cayman Islands and listed in Hong Kong, operates in the healthcare and consumer products sector, best known for throat lozenges and related products. The group focuses on the mainland China market, where it derives the bulk of its revenue from the manufacture and sale of branded lozenge and healthcare items.

**Average Trading Volume:** 811,158

**Technical Sentiment Signal:** Strong Buy

**Current Market Cap:** HK$2.64B

### 相关股票

- [GOLDEN THROAT (06896.HK)](https://longbridge.com/zh-CN/quote/06896.HK.md)

## 相关资讯与研究

- [22:00 ETHEARTS ON FIRE CELEBRATES 30 YEARS OF BRILLIANCE WITH NEW GLOBAL CAMPAIGN WHAT'S YOUR SIGNATURE?](https://longbridge.com/zh-CN/news/281450272.md)
- [ZAWYA: Cambridge Health Group announces 70 bed expansion of Cambridge Hospital Jeddah](https://longbridge.com/zh-CN/news/281484041.md)
- [JD Logistics Grants New Employee Share Awards with Robust Clawback Terms](https://longbridge.com/zh-CN/news/281373299.md)
- [10:41 ETPaessler Warns That Separate IT and OT Monitoring Has Become a Critical Business Risk in 2026](https://longbridge.com/zh-CN/news/281042496.md)
- [13:21 ETNozzlePro Launches E-Commerce for Pressure Wash Nozzles, Enabling Instant Checkout and Transparent Pricing](https://longbridge.com/zh-CN/news/281406376.md)